SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899866-19-000080
Filing Date
2019-07-15
Accepted
2019-07-15 17:01:00
Documents
1
Period of Report
2019-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156322444530801.html 4  
1 FORM 4 wf-form4_156322444530801.xml 4 3340
  Complete submission text file 0000899866-19-000080.txt   4790
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
Clancy Paul J (Reporting) CIK: 0001409601 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27756 | Film No.: 19955638